# SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects

> **NCT06652997** · PHASE1 · COMPLETED · sponsor: **West China Second University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Antitumor Drug
- Pharmacokinetics

## Interventions

- **DRUG:** SPH3348

## Key facts

- **NCT ID:** NCT06652997
- **Lead sponsor:** West China Second University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-15
- **Primary completion:** 2022-08-14
- **Final completion:** 2022-11-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06652997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06652997, "SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06652997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*